CB-21 (Cartography Biosciences)

N/A

Report date: 2026/03/19 17:14:54

Base Information

Drug NameCB-21 (Cartography Biosciences)

Drug Alias NameCB21 TCECB-21

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionLymphocyte antigen 6 complex locus protein G6d modulatorsT cell surface glycoprotein CD3 modulators

TargetsLymphocyte antigen 6 complex locus protein G6dT cell surface glycoprotein CD3

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCartography Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCartography Biosciences Inc

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A